Published in Drug Law Weekly, May 8th, 2007
The letter of intent calls for an exclusivity period during which the definitive agreement is to be finalized. This agreement will be submitted to Spherix's stockholders for approval. It is expected that the transaction can be completed by the end of the summer.
The sale will allow Spherix to focus all of its efforts on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.